Effects on candidate DLBCL co-driver gene expression were also defined, including Rgs1, an inhibitor of lymphocyte migration (60), and GTPase Rab10, which (like HGAL) is elevated in DLBCL patients with extended OS (61). This evidence concerns the gene GCSAM and diffuse large B-cell lymphoma.